• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

BioMarin Pharmaceutical Inc

+ Add to Watchlist


82.7599 USD 2.1999 2.73%

As of 12:01:14 ET on 10/30/2014.

Snapshot for BioMarin Pharmaceutical Inc (BMRN)

Open: 80.3200 Day's Range: 79.8900 - 83.0400 Volume: 264,164
Previous Close: 80.5600 52wk Range: 55.0400 - 84.2500 1-Yr Rtn: +30.22%

Stock Chart for BMRN

No chart data available.
  • BMRN:US 82.7599
  • 1D
  • 1M
  • 1Y
Interactive BMRN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BMRN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.0991
Est. EPS (USD) (12/2014) -0.8280
Est. PEG Ratio -
Market Cap (M USD) 11,879.82
Shares Outstanding (M) 147.47
30 Day Average Volume 1,242,438
Price/Book (mrq) 8.0781
Price/Sale (ttm) 17.9857
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BMRN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BMRN

BioMarin Pharmaceutical Inc. develops and commercializes therapeutic enzyme products. The Company has applied its proprietary enzyme technology to develop products for lysosomal storage diseases and for the treatment of serious burns. BioMarin's subsidiary provides analytical and diagnostic products and services in the area of carbohydrate biology.

Jean-Jacques BienaimeChief Executive OfficerDaniel K Spiegelman "Dan"Exec VP/CFO
Jeff AjerExec VP/Chief Commercial OfcrHenry J FuchsExec VP/Chief Medical Officer
More Company Profile & Key Executives for BMRN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil